Enlaza Therapeutics
Signal active
Organization
Contact Information
Overview
Enlaza Therapeutics is a biotechnology research company. It was founded in 2020 and is headquartered in La Jolla, California.
About
Industries
Biotechnology, Health Care, Biopharma, Therapeutics
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Enlaza Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $7.9B in funding across 48 round(s). With a team of 11-50 employees, Enlaza Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Enlaza Therapeutics, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$165.0M
Details
3
Enlaza Therapeutics has raised a total of $165.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 61.0M | ||
| 2024 | Early Stage Venture | 100.0M | ||
| 2021 | Seed | 4.0M |
Investors
Enlaza Therapeutics is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Amgen Ventures | - | FUNDING ROUND - Amgen Ventures | 100.0M |
| Stephen Squinto | - | FUNDING ROUND - Stephen Squinto | 100.0M |
| Enlaza Therapeutics | - | FUNDING ROUND - Enlaza Therapeutics | 100.0M |
| J.P. Morgan Asset Management | - | FUNDING ROUND - J.P. Morgan Asset Management | 100.0M |
Recent Activity
There is no recent news or activity for this profile.